Antiviral properties of trans-δ-viniferin derivatives against enveloped viruses.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 Jul

filter terms:

Over the last century, the number of epidemics caused by RNA viruses has increased and the current SARS-CoV-2 pandemic has taught us about the compelling need for ready-to-use broad-spectrum antivirals. In this scenario, natural products stand out as a major historical source of drugs. We analyzed the antiviral effect of 4 stilbene dimers [1 (trans-δ-viniferin); 2 (11',13'-di-O-methyl-trans-δ-viniferin), 3 (11,13-di-O-methyl-trans-δ-viniferin); and 4 (11,13,11',13'-tetra-O-methyl-trans-δ-viniferin)] obtained from plant substrates using chemoenzymatic synthesis against a panel of enveloped viruses. We report that compounds 2 and 3 display a broad-spectrum antiviral activity, being able to effectively inhibit several strains of Influenza Viruses (IV), SARS-CoV-2 Delta and, to some extent, Herpes Simplex Virus 2 (HSV-2). Interestingly, the mechanism of action differs for each virus. We observed both a direct virucidal and a cell-mediated effect against IV, with a high barrier to antiviral resistance; a restricted cell-mediated mechanism of action against SARS-CoV-2 Delta and a direct virustatic activity against HSV-2. Of note, while the effect was lost against IV in tissue culture models of human airway epithelia, the antiviral activity was confirmed in this relevant model for SARS-CoV-2 Delta. Our results suggest that stilbene dimer derivatives are good candidate models for the treatment of enveloped virus infections. Copyright © 2023. Published by Elsevier Masson SAS.

Citation

Arnaud Charles-Antoine Zwygart, Chiara Medaglia, Robin Huber, Romain Poli, Laurence Marcourt, Sylvain Schnee, Emilie Michellod, Beryl Mazel-Sanchez, Samuel Constant, Song Huang, Meriem Bekliz, Sophie Clément, Katia Gindro, Emerson Ferreira Queiroz, Caroline Tapparel. Antiviral properties of trans-δ-viniferin derivatives against enveloped viruses. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2023 Jul;163:114825